A study to evaluate the effect of letrozole and tamoxifen on bone and lipids in postmenopausal women with breast cancer
Phase of Trial: Phase III
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Letrozole (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Pharmacodynamics
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2012 Additional location (England) added and additional lead trial centres identified as reported by ClinicalTrials.gov.
- 01 Jun 2012 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.